GlobeNewswire•8 minutes agoLeads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage9887.HK5.07%
ACCESS Newswire•13 minutes agoSCIB Records RM6.31 Million Q2 FY2026 PAT as Strategic Transformation Advances9237.KL0.00%